Skip to main content

Susan Windham-Bannister

Equibles does not estimate personal net worth.

About Susan Windham-Bannister

Susan Windham-Bannister is recorded as Board Member at Humacyte, Inc. (HUMA) since January 1, 2021. The newest filing on record that lists Susan Windham-Bannister as Board Member at Humacyte, Inc. (HUMA) is dated April 28, 2026. Humacyte, Inc. reported in an 8-K filed June 13, 2024 that Susan Windham-Bannister was appointed Class III Director, effective June 11, 2024. Humacyte, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Humacyte, Inc. includes Laura E. Niklason (CEO and Board Member), Laura Niklason (CEO and Board Member), Dale A. Sander (CFO) and 7 others.

“The stockholders elected each of the six Class III directors who were nominated to serve until the Company's 2027 annual meeting of stockholders or until such director's successor is elected, or until such director's earlier death, resignation or removal.”
Humacyte, Inc. Form 8-K, filed June 13, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2021-01-01–present

Leadership on record at Humacyte, Inc.

Recent activity